| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |